Andrea Silber - Concepedia

Concepedia

Author

Andrea Silber

Yale Cancer Center ORCID

Also Known As

A Silber, A. Silber, Andrea L M Silber, Andrea L Silber, Andrea L. Silber, Andrea L.M. Silber, Andrea Silber, Kwaramba, Tendai, Silber, Andrea

100

Publications

1.4K

Citations

18

H-Index

52

Concepts

All Affiliations

Yale Cancer Center Yale University The University of Texas MD Anderson Cancer Center Sarah Cannon Tennessee Oncology

AS

About

Andrea Silber is an author at Yale Cancer Center specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	613
2	Health Sciences	3	3	52
3	Public Health	3	3	251
4	Arts	1	1	33
5	Nursing	1	1	23

Andrea Silber

×

27

Publications

1.4K

Citations

18

H-Index

	Year	Citations
Immunological differences between primary and metastatic breast cancer Borbála Székely, Veerle Bossuyt, Xiaofeng Li, Annals of Oncology	2018	357
Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology Peter G. Shields, Roy S. Herbst, Douglas A. Arenberg, Journal of the National Comprehensive Cancer Network Tobacco CessationCancer ManagementCancer EducationTobacco ControlOncology	2016	146
Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study Tara Sanft, Maura Harrigan, Courtney McGowan, Journal of Clinical Oncology	2023	76
Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups Bruce G. Haffty, Doo Ho Choi, Sharad Goyal, Annals of Oncology Breast OncologyCancer RiskCancer EpidemiologyMedicineBrca1/2 Mutations	2009	68
New Therapeutic Strategies for Triple-Negative Breast Cancer. Borbála Székely, Andrea Silber, Lajos Pusztai PubMed Tumor BiologyMolecular HeterogeneityBreast OncologyResidual CancerMedicine	2017	68
Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women Tess A. O’Meara, Anton Safonov, David Casadevall, Breast Cancer Research and Treatment Breast OncologyCancer ImmunosurveillanceCancer EpidemiologyImmune MicroenvironmentMedicine	2019	66
Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer Julia Foldi, Andrea Silber, Emily Reisenbichler, npj Breast Cancer	2021	66
Increased Arabinitol Levels in Experimental Candidiasis in Rats: Arabinitol Appearance Rates, Arabinitol/Creatinine Ratios, and Severity of Infection Brian Wong, E M Bernard, Jonathan Gold, The Journal of Infectious Diseases UrologyRenal FunctionArabinitol LevelsAntifungal AgentExperimental Candidiasis	1982	60
Bidirectional Text Messaging to Monitor Endocrine Therapy Adherence and Patient-Reported Outcomes in Breast Cancer Sarah S. Mougalian, Lianne Epstein, Ami P. Jhaveri, JCO Clinical Cancer Informatics	2017	43
Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer Tara Sanft, Bilge Aktaş, Brock E. Schroeder, Breast Cancer Research and Treatment	2015	42

Page 1